13 - 14 November 2019, Rome, Italy
ViewRay is dedicated to supporting the MRIdian system in the international markets, and ensuring we continue to foster our relationship with our early adopters who are paving the way for patients to benefit from this groundbreaking technology.
To help strengthen the MRIdian user community, we will host the 2019 EMEA ViewRay Users' Meeting on 13 November 2019 to share best practices, foster networking and advance the science of MR guided RT. The day following this event, ViewRay will host a Symposium for clinicians considering the purchase of the MRIdian system. The day will feature presentations by many current MRIdian users and is designed to help educate clinicians on the strategic, economic, clinical and technical aspects of the MRIdian. After the Symposium, attendees will be given a tour of Gemelli ART to see MRIdian in action.
For more information or to be invited to these events, please email Heather Schmidt at email@example.com.
8:00 - 18:30
MRIdian Users' Meeting
The Westin Excelsior, Rome
Via Vittorio Veneto, 125
Via Sardinia, 28
9:00 - 17:00
Symposium and Tour
A. Gemelli University Hospital
Largo Agostino Gemelli, 8
*Transportation will be provided between the Westin Excelsior and Gemelli ART
Via Sardinia, 28
*This is an invite-only dinner and seating is limited. Please RSVP.
With added clarity provided by MRIdian real-time imaging, physicians are better equipped to account for any motion caused by respiration or other bodily processes and personalize each treatment.
First pioneered by ViewRay in 2012, MRI-Guided ROAR™ (Real-time On-table Adaptive Radiotherapy) represents a new paradigm in cancer treatment. It provides clinicians with the ability to improve targeting precision and accuracy to deliver higher, and potentially more effective, radiation doses.
Watch the video below: